Small Molecule Nitazoxanide Inhibits Osteogenic Differentiation and Promotes Adipogenic Differentiation of Bone Marrow Mesenchymal Stem Cells.

Chan Yuan Jin,Yan,Xiao Mei Hou,Zhi Hui Tang
DOI: https://doi.org/10.3290/j.cjdr.b4128019
2023-01-01
Abstract:Objective: To investigate the potential effect of small molecule nitazoxanide (NTZ) on the osteogenic and adipogenic differentiation of bone marrow mesenchymal stem cells (BMSCs).Methods: Cell counting Kit-8 assay was used to examine the effect of NTZ on proliferation of BMSCs. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blot analysis were used to measure the expression of osteogenic and adipogenic marker gene. Alkaline phosphatase (ALP) staining and activity assay and Alizarin Red S (ARS) staining were used to investigate the effect of NTZ on osteogenesis. Oil red 0 (ORO) staining assay was used to assess the impact of NTZ on adipogenesis.Results: NTZ significantly suppressed the osteogenic differentiation but promoted the adipo-genic differentiation of BMSCs. Mechanistically, NTZ regulated osteogenic/adipogenic dif-ferentiation of BMSCs by inhibiting the Wnt/O-catenin signalling pathway. The addition of Wnt/O-catenin signalling pathway activator, lithium chloride, could reverse the effect of NTZ on BMSCs.Conclusion: NTZ affected osteogenic and adipogenic differentiation of BMSCs with the involve-ment of Wnt/O-catenin signalling pathway. This finding expanded the understanding of NTZ pharmacology and indicated that NTZ might have an adverse effect on bone homeostasis.
What problem does this paper attempt to address?